- Open Access
Reassessment of asymptomatic carriers of Plasmodium spp. in an endemic area with a very low incidence of malaria in extra-Amazonian Brazil
© The Author(s) 2017
Received: 10 April 2017
Accepted: 2 November 2017
Published: 9 November 2017
Regions with residual transmission are potential obstacles to the elimination of malaria. It is, therefore, essential to understand the factors associated with the maintenance of endemic malaria in these areas. The objective was to investigate whether the status of asymptomatic carriers of Plasmodium spp. DNA is maintained in the long term in an extra-Amazonian region of Brazil with low incidence, residual malaria transmission.
Asymptomatic carriers of Plasmodium DNA detected in a survey carried out between 2001 and 2004 were reassessed between 2010 and 2011 using questionnaires, PCR and thick and thin blood smear tests three times at 3-month intervals.
Of the 48 carriers detected between 2001 and 2004, 37 were located. Of these, only two had positive PCR results and, as in the first survey, Plasmodium malariae DNA was detected.
The findings suggest that untreated dwellers from this extra-Amazonian region, who initially harbour malaria parasites, may become negative without ever developing apparent symptoms of the disease. Although the possibility of re-infection cannot be ruled out, the finding of two individuals harbouring P. malariae, both in the first and in the second survey, may be compatible with a long-term carrier state for this parasite. Since most clinical cases of malaria in the region are a consequence of infection by Plasmodium vivax, the epidemiological impact of such long-term carriage would be limited.
Although malaria control efforts have reduced the impact of the disease around the world, there were an estimated 212 million cases worldwide in 2015, leading to 429,000 deaths . Despite the reduced incidence of the disease in most transmission areas as a result of malaria control strategies, the existence of residual transmission in some regions, such as parts of the Atlantic Forest in extra-Amazonian Brazil, can make it difficult to achieve the goal of worldwide elimination of the disease.
Residual malaria in the Atlantic Forest in Brazil has a very low incidence in various states along the coast. The greatest number of reported cases in these states is in Espírito Santo , where the disease occurs in the mountainous region, which lies no more than 50 km on average from the coast. Seventeen to 68 cases are reported every year in an area covering approximately 5343 sq km . In a survey carried out in this area between 2001 and 2004 , Plasmodium vivax was identified in 48 of the 51 symptomatic individuals previously diagnosed as malaria cases by both microscopic examination of blood films and polymerase chain reaction (PCR) who were asked to participate in the survey. Plasmodium malariae DNA was identified by PCR in one sample, and in two samples blood smear tests revealed parasites morphologically similar to P. vivax but the PCR was negative. At the same time, 1527 blood samples were collected from residents of the areas where cases were reported and tested by multiplex PCR and microscopic analysis of blood films (thick and thin smears) to identify asymptomatic carriers. Plasmodium vivax DNA was detected by PCR in 23 of the samples, P. malariae DNA in 15, Plasmodium falciparum DNA in nine, and P. falciparum and P. malariae DNA in one. No parasites were observed in the thick smears of these asymptomatic carriers.
Understanding the transmission chain associated with endemic malaria maintained in such a vast area with such a low frequency of symptomatic and asymptomatic cases is a considerable challenge. According to one hypothesis, this behaviour may be typical of a zoonosis and the human cases may be a result of incidental transmission of locally occurring simian malaria [5–7], which in Brazil is caused by two Plasmodium species, Plasmodium brasilianum and Plasmodium simium. The genetic similarity between P. vivax and P. simium and between P. malariae and P. brasilianum [8, 9] reinforces the possibility of a zoonosis, with simians acting as reservoirs in the transmission cycle involving humans. However, despite the low frequency of the cases, it is important to determine whether the low-endemic malaria could be maintained by asymptomatic human carriers. The aim of this study was therefore to reassess, clinically and parasitologically, the individuals who in the first survey tested positive for the presence of Plasmodium DNA in the bloodstream. Consequently, this reassessment enables the verification of long-term positivity for Plasmodium DNA and clinical evolution to apparent disease, contributing to the understanding of the role of asymptomatic carriers in the sustained transmission of malaria among humans in this endemic area.
Of 48 asymptomatic individuals who were positive for Plasmodium DNA in the first survey (between 2001 and 2004), 37 were located in 2010 and included in the study. The remaining 11 consisted of three who had died of causes unrelated to malaria (stroke, acute myocardial infarction and respiratory insufficiency secondary to chronic obstructive pulmonary disease), one who refused to take part in the study and seven who had moved and could not be located. Each of the individuals located was asked to provide a blood sample once every 3 months on three separate occasions to investigate the presence of Plasmodium DNA. Before the first collection the participants signed a voluntary informed-consent form. On each occasion a questionnaire was filled out covering demographic data and any instances since the previous collection of febrile illnesses, thick-smear tests for malaria or trips outside the area where the participant lived. A total of 5 mL of blood was then collected in vacutainer tubes (BD Vacutainer™, New Jersey USA) containing EDTA, thick and thin peripheral blood smears were prepared and the subject’s spleen was palpated by the physicians in charge of the project (FECA and CCJ).
The blood collected was centrifuged at 300g for 10 min in the Protozoology Laboratory in the Tropical Medicine Unit, Federal University of Espírito Santo, to separate the plasma from the red blood cells. These were then aliquoted and stored at − 20 °C in Eppendorf tubes, which were sent to the Protozoology Laboratory at the São Paulo Institute of Tropical Medicine, where DNA was extracted and PCR was performed.
Thick and thin smears
Thick and thin blood smears were prepared following the method recommended by the World Health Organization . The smears were examined under an optical microscope at 1000 × magnification in the malaria sector of the Central Public Health Laboratory of the State of Espírito Santo by experienced senior microscopists. The results were based on examination of at least 200 microscopic fields.
Amplification of Plasmodium DNA
Genomic DNA was extracted from the samples with the NucleoSpin Tissue purification kit (Macherey–Nagel) following the manufacturer’s instructions. The PCR procedure followed Win et al. . Briefly, nested-PCR, which consists of two rounds of amplification, was carried out with primers that target the Plasmodium 18S RNA gene sub-unit. The first step was carried out in a final volume of 20 µL containing 0.8 µL of each primer, P1UP and P2 (10 µM), 0.25 µL of dNTP mix (10 mM each, Thermo Fisher Scientific), 2 µL of 10 × PCR buffer, 1 µL of MgCl2 (50 mM), 0.16 µL of Platinum Taq DNA polymerase-Invitrogen (5 U/µL) and 5 µL of DNA. The amplification was run in an Applied Biosystems thermocycler with the following programme: 92 °C for 2 min, 35 cycles of 92 °C for 30 s and 60 °C for 90 s and one cycle of 60 °C for 5 min.
The product from the first step was diluted 1:50 in sterile water and used in the second step with the P1 (genus–specific) primer and one of the three reverse species-specific primers (V1—P. vivax, F2—P. falciparum or M1—P. malariae).
This step was carried out in a final volume of 20 µL containing 2 µL of each primer (10 µM), 0.5 µL of dNTP (10 mM each, Thermo Fisher Scientific), 2 µL of 10 × PCR buffer, 0.16 µL of Taq DNA polymerase (5 U/µL) and 2 µL of the diluted final product from the first step. The second amplification was carried out in the same equipment as the first, and the cycling parameters were 92 °C for 2 min followed by 18 cycles of 92 °C for 30 s and 60 °C for 1 min and one cycle of 60 °C for 5 min. The amplified products of the second step correspond to species-specific fragments of about 100 bp.
- P1UP (F)::
5′ TCC ATT AAT CAA GAA CGA AAG TTA AG 3′
- P2 (R)::
5′ GAA CCC AAA GAC TTT GAT TTC TCA T 3′
- P1 (F)::
5′ ACG ATC AGA TAC CGT CGT AAT CTT 3′
- V1 (R)::
5′ CAA TCT AAG AAT AAA CTC CGA AGA GAA A 3′
- F2 (R)::
5′ CAA TCT AAA AGT CAC CTC GAA AGA TG 3′
- M1 (R)::
5′ GGA AGC TAT CTA AAA GAA ACA CTC ATA T 3′.
DNA extracted from peripheral blood of P. vivax malaria patients treated at the São Paulo Department for the Control of Endemic Diseases (SUCEN), from P. falciparum cultures and from blood smears positive for P. malariae provided by the Centers for Disease Control and Prevention (CDC) was used as a control.
The amplified product was run on 2% agarose gel at 80 V for 40 min. The gel was stained in ethidium bromide, and the bands were visualized under a UV transilluminator.
Quantitative variables were expressed as medians and interquartile ranges, and categorical variables were expressed as absolute and relative frequencies. The data were analysed with SPSS version 17.0 (IBM Statistical Package for Social Sciences).
Of the cohort of 48 individuals found to be Plasmodium DNA carriers in the first survey, 37 participated in the study and provided blood samples on three different occasions between April 2010 and March 2011. Fifteen (40.5%) of the samples from these 37 asymptomatic carriers had been positive for P. vivax DNA in the 2001–2004 survey, 12 (32.4%) for P. malariae DNA, 9 (24.3%) for P. falciparum DNA, and one (2.7%) for P. falciparum and P. malariae DNA.
Demographic data for 37 residents of a residual malaria transmission area in an Atlantic Forest system
Frequency, n (%)
Six individuals said they had not left the region where they lived during the study. All those who had left the region between the three collections went to nearby municipalities, some of which had residual malaria transmission.
Fourteen individuals reported experiencing fever during the follow-up in at least one of the interviews. In all but one case, in which it subsided after a week, the fever lasted 1–4 days. None of those who presented with fever was tested for malaria by the local health services, and their fevers cleared without any specific treatment. In two individuals the spleen was palpable at the costal margin, in one only at the first collection and in the other at all three collections. Blood smears in both patients were negative for Plasmodium spp., and DNA was not amplified in the multiplex PCR. The individual whose spleen was palpable throughout the follow-up (individual no. 34) was seen by the paediatric service at the University Hospital, but the aetiology of the splenomegaly could not be determined. The splenomegaly subsequently regressed and the spleen was no longer palpable.
Data for individuals who were positive by PCR in the 2001–2004 and 2010–2011 surveys in a residual malaria transmission area in an Atlantic Forest system
Municipality where individual was living
Santa Maria de Jetibá
Santa Maria de Jetibá
Species identified by PCR
Municipality where individual was living
Santa Maria de Jetibá
Santa Maria de Jetibá
Species identified by PCR
In this study to investigate the persistence of DNA positivity in a cohort of 37 asymptomatic carriers approximately 6 years after an earlier survey, only two patients with a molecular diagnosis consistent with P. malariae infection in the first survey still tested positive for P. malariae DNA in at least one of the blood samples collected in the present survey, possibly indicating a prolonged, low-parasitaemia infection. This behaviour is expected for a parasite known to circulate unnoticed for long periods in the bloodstream of infected individuals. However, 94.5% of all the asymptomatic carriers assessed were no longer positive for Plasmodium DNA regardless of the species originally detected, and positivity for P. malariae DNA was observed in only 15.4% (2 out of 13) of the individuals found to be carriers of this species in the first survey. Additionally, none of them developed symptoms compatible with malaria in the period between the first survey and the reassessment.
The role of asymptomatic individuals  in the malaria transmission chain in areas where there is a low incidence of the disease has been investigated in various studies in recent years [4, 13–17]. A better understanding of the part played by asymptomatic infections in malaria transmission is essential to implement and improve malaria elimination and eradication programmes. The fact that asymptomatic carriers are not identified by methods currently in regular use is an obstacle to malaria elimination. One of the most important consequences of asymptomatic infection is that those affected do not seek medical assistance or treatment and may therefore help to maintain the malaria cycle.
In an area such as that studied here, where malaria is uncommon and the population would not generally consider it a cause of fever, even people who have been given guidance about the disease do not normally go to medical centres to be tested for malaria infection, unlike in regions of the Amazon where there is a higher incidence of the disease.
In areas of the Atlantic Forest where there is residual malaria and very low endemicity, thick blood smears normally reveal low parasitaemia in symptomatic patients . Most of the infections in these symptomatic individuals are caused by P. vivax . As the thick smear test has low sensitivity, a negative result does not necessarily exclude residual parasitaemia. It is thus possible that the absence of definitive clearance of parasitaemia, leading to maintenance of a small number of parasites only detectable by molecular methods, means that patients who are apparently cured in fact act as suppliers of gametocytes, helping to maintain the transmission cycle [18–25].
In a study in the Amazon region, Alves et al. found that even though they were asymptomatic, patients who had exhibited very low parasitaemia, that could only be detected by PCR 2 months before they were recruited to the study to assess their capacity to infect mosquitoes, remained infective. However, they had less infective capacity than the symptomatic patients. They cited unpublished data showing that 40% of the asymptomatic patients were negative by PCR after 2 months of follow-up and suggested that the limited capacity of asymptomatic patients to infect mosquitoes may be made up for by carriage of Plasmodium over long periods, potentially maintaining transmission cycles in some regions .
An issue that remains to be elucidated is the detection of P. falciparum DNA in 10 asymptomatic individuals in the transmission area during the 2001–2004 survey. To date there have been no cases of malaria caused by this species in the region in question, and P. falciparum is not considered an aetiologic agent of malaria in Atlantic Forest systems. Recently, Maselli et al.  also detected P. falciparum DNA in asymptomatic blood donors who had been in the Atlantic Forest system in the state of São Paulo, a state where there have not been any reports of symptomatic cases of this type of malaria among local residents. It is possible that detection of P. falciparum could be a result of the molecular technique used. In the 2001–2004 study , it was used a multiplex PCR described by Rubio et al. . As the use of multiplex PCR may have affected the specificity of the test, the finding of P. falciparum DNA in this region may represent artifacts of the technique, indicating the presence of a species that is not in fact part of the transmission chain . Nevertheless, in a recent study in fragments of Atlantic Forest in the southeast of Brazil, Laporta et al.  identified anophelines naturally infected with P. falciparum and P. vivax, the latter in a smaller proportion of the infected mosquitoes. This was confirmed by DNA sequencing, which identified P. falciparum in 76% of the positive specimens, most of which were Anopheles cruzii, suggesting that P. falciparum circulates actively among Anopheles in fragmented areas of the Atlantic Forest in this region of Brazil. In light of these unresolved questions, further studies are needed before the role of P. falciparum in the aetiology of residual malaria in Atlantic Forest systems can be determined.
The limitations of this study should also be taken into consideration, as many years had elapsed since the first study, making it difficult to obtain reliable information about the period during which the individuals in the original survey were not followed up. It is not possible to assert without any doubt that the two individuals infected by P. malariae in the present survey were not re-infected after the first survey. However, the presence of the same species of parasite in both surveys and the potential for infections of very long duration observed for this species of parasite make it possible that they are the same infections. It should be emphasized that asymptomatic individuals are not treated for malaria in the study area. Consequently, specific treatment does not represent confounding. Information about any symptoms experienced by the participants between blood collections was provided by the participants themselves. At the time of the collections, however, they were all asymptomatic. None of the individuals who reported having had a fever sought medical assistance to be tested for malaria and in all of them the symptoms improved without the use of anti-malarial medication.
The study’s importance lies in its novelty, as it is the first reassessment of asymptomatic carriers following a prolonged interval of time between surveys. In this cohort, even though asymptomatic carriers were not followed up over a very long period and it was not possible to determine with a reasonable degree of accuracy when DNA tests were no longer likely to be positive, most of the patients who were positive for some of the species in the first survey were no longer positive in this study, apart from two patients who were positive for P. malariae. Therefore, although it has been suggested that asymptomatic carriers should be treated , treatment in these cases seems clinically irrelevant since the patients with sub-microscopic parasitaemia in the study region, where endemicity is very low, spontaneously ceased to test positive without a specific treatment for malaria. Since most clinical cases of malaria in the region are a consequence of infection by P. vivax, the epidemiological impact of a possible long-term carriage of P. malariae is limited.
FECA participated in the study design, data collection in the field and data analysis and wrote the first draft of the manuscript; RSM participated in the study design, performed the laboratory tests, organized the data and contributed to the organization of the manuscript; CCJ participated in the study conception, study design, data collection in the field and data analysis and helped to prepare the first draft of the manuscript; LNF performed the laboratory tests, organized the data and contributed to the organization of the manuscript; JCB participated in the data collection in the field, storage of the samples, organization of the data and improvement of the manuscript; HRR helped to coordinate the field logistic, participated in the organization of the data and helped in the improvement of the manuscript; BF participated in the processing and storage of samples and in the data analysis; ABM coordinated the work carried out by the team, participated in study design, contributed to the data analysis and produced the final version of the manuscript. All authors read and approved the final manuscript.
The authors would like to thank the population of the rural area where the study was carried out, who understood the objectives of the study and whose extensive participation helped to ensure its success. We are also grateful to the Espírito Santo State Department of Health (SESA) for supplying logistical support and material.
The authors declare that they have no competing interests.
Availability of data and materials
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
Consent for publication
As the data were primarily collected for this project, it was not necessary any consent from third parties. Signed consent forms were obtained from all the individuals included in the study.
Ethics approval and consent to participate
The study was approved by the Committee for Ethics in Research at the Centre for Health Sciences, Federal University of Espírito Santo, under Ref. No. 079/09. Before the first collection the participants signed a voluntary informed-consent form.
This project was financed by the State of Espírito Santo Research Foundation (FAPES) (Grant No. 45617600/2009) and the State of São Paulo Research Foundation (FAPESP) (Grant No. 10/50707-5).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. World malaria report 2016. Geneva: World Health Organization; 2016.Google Scholar
- de Pina-Costa A, Brasil P, Di Santi SM, de Araujo MP, Suárez-Mutis MC, Santelli AC, et al. Malaria in Brazil: what happens outside the Amazonian endemic region. Mem Inst Oswaldo Cruz. 2014;109:618–33.View ArticlePubMedPubMed CentralGoogle Scholar
- Brazilian Ministry of Health. DATASUS [Homepage] MALÁRIA-Casos confirmados Notificados no Sistema de Informação de Agravos de Notificação-Espírito Santo. Brazilian Ministry of Health: Brasília. 2017. http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinannet/cnv/malaes.def. Accessed 16 Feb 2017.
- Cerutti C Jr, Boulos M, Coutinho AF, Hatab MCLD, Falqueto A, Rezende HR, et al. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J. 2007;6:33.View ArticlePubMedGoogle Scholar
- Deane LM. Simian malaria in Brazil. Mem Inst Oswaldo Cruz. 1992;87(Suppl 3):1–20.View ArticlePubMedGoogle Scholar
- Duarte AMRC, Malafronte RS, Cerutti C, Curado I, de Paiva BR, Maeda AY, et al. Natural Plasmodium infections in Brazilian wild monkeys: reservoirs for human infections? Acta Trop. 2008;107:179–85.View ArticlePubMedGoogle Scholar
- Yamasaki T, Duarte AM, Curado I, Summa ME, Neves DV, Wunderlich G, et al. Detection of etiological agents of malaria in howler monkeys from Atlantic Forests, rescued in regions of São Paulo city, Brazil. J Med Primatol. 2011;40:392–400.View ArticlePubMedGoogle Scholar
- Li J, Collins WE, Wirtz RA, Rathore D, Lal A, McCutchan TF. Geographic subdivision of the range of the malaria parasite Plasmodium vivax. Emerg Infect Dis. 2001;7:35–42.View ArticlePubMedPubMed CentralGoogle Scholar
- Tazi L, Ayala FJ. Unresolved direction of host transfer of Plasmodium vivax v. P. simium and P. malariae v. P. brasilianum. Infect Genet Evol. 2011;11:209–21.View ArticlePubMedGoogle Scholar
- WHO. Basic malaria microscopy. Geneva: World Health Organization; 1991.Google Scholar
- Win TT, Lin K, Mizuno S, Zhou M, Liu Q, Ferreira MU, et al. Wide distribution of Plasmodium ovale in Myanmar. Trop Med Int Health. 2002;7:231–9.View ArticlePubMedGoogle Scholar
- Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg. 2002;66:641–8.View ArticlePubMedGoogle Scholar
- Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, et al. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J. 2005;4:27.View ArticlePubMedPubMed CentralGoogle Scholar
- Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J. 2010;9:254.View ArticlePubMedPubMed CentralGoogle Scholar
- Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission: what is the evidence? Trends Parasitol. 2014;30:183–90.View ArticlePubMedPubMed CentralGoogle Scholar
- Maselli LM, Levy D, Laporta GZ, Monteiro AM, Fukuya LA, Ferreira-da-Cruz MF, et al. Detection of Plasmodium falciparum and Plasmodium vivax subclinical infection in non-endemic region: implications for blood transfusion and malaria epidemiology. Malar J. 2014;13:224.View ArticlePubMedPubMed CentralGoogle Scholar
- Baum E, Sattabongkot J, Sirichaisinthop J, Kiattibutr K, Davies DH, Jain A, et al. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand—molecular and serological evidence. Malar J. 2015;14:95.View ArticlePubMedPubMed CentralGoogle Scholar
- Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, et al. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007;76:470–4.PubMedGoogle Scholar
- Babiker HA, Schneider P, Reece SE. Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol. 2008;24:525–30.View ArticlePubMedPubMed CentralGoogle Scholar
- Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, et al. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J. 2008;7:249.View ArticlePubMedPubMed CentralGoogle Scholar
- Wampfler R, Mwingira F, Javati S, Robinson L, Betuela I, Siba P, et al. Strategies for detection of Plasmodium species gametocytes. PLoS ONE. 2013;8:e76316.View ArticlePubMedPubMed CentralGoogle Scholar
- Ouédraogo AL, Bousema T, Schneider P, De Vlas SJ, Ilboudo-Sanogo E, Cuzin-Ouattara N, et al. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS ONE. 2009;4:e8410.View ArticlePubMedPubMed CentralGoogle Scholar
- Bousema T, Drakeley C. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev. 2011;24:377–410.View ArticlePubMedPubMed CentralGoogle Scholar
- Pett H, Gonçalves BP, Dicko A, Nébié I, Tiono AB, Lanke K, et al. Comparison of molecular quantification of Plasmodium falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity. Malar J. 2016;15:539.View ArticlePubMedPubMed CentralGoogle Scholar
- Vallejo AF, Garcia J, Amado-Garavito AB, Arévalo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016;15:48.View ArticlePubMedPubMed CentralGoogle Scholar
- Alves FP, Gil LH, Marrelli MT, Ribolla PE, Camargo EP, Da Silva LH. Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon. J Med Entomol. 2005;42:777–9.View ArticlePubMedGoogle Scholar
- Rubio JM, Benito A, Roche J, Berzosa PJ, García ML, Micó M, et al. Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. Am J Trop Med Hyg. 1999;60:183–7.View ArticlePubMedGoogle Scholar
- Mendrone A Jr, Cerutti C Jr, Levi JE, Boulos M, Sanchez MC, Malafronte R dos S, et al. Unexpected detection of Plasmodium vivax and Plasmodium falciparum DNA in asymptomatic blood donors: fact or artifact? Malar J. 2014;13:336.View ArticlePubMedPubMed CentralGoogle Scholar
- Laporta GZ, Burattini MN, Levy D, Fukuya LA, Oliveira TMP, et al. Plasmodium falciparum in the southeastern Atlantic forest: a challenge to the bromeliad-malaria paradigm? Malar J. 2015;14:181.View ArticlePubMedPubMed CentralGoogle Scholar